Early research (Phase 1)Study completedNCT05411965
What this trial is testing
Evaluate the Pharmacokinetics After Administration of BR3003 and Co-administration of BR3003B and BR3003C.
Who this might be right for
Diabetes Mellitus, Type 2
Boryung Pharmaceutical Co., Ltd 48